Data are limited regarding the use of direct-acting antivirals for treatment of hepatitis C infection post lung transplant, especially in a donor-derived infection. We present a case of a lung transplant recipient with donor-derived hepatitis C that was successfully treated with a 12-week regimen of simeprevir and sofosbuvir. This case reiterates the importance of screening recipients of increased-risk donor organs for disease transmission and the value of early therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/tid.12659 | DOI Listing |
Publication Analysis
Top Keywords
lung transplant
12
donor-derived hepatitis
8
hepatitis infection
8
transplant recipient
8
successful treatment
4
treatment donor-derived
4
infection lung
4
recipient data
4
data limited
4
limited direct-acting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!